Cinacalcet

Treatment of secondary hyperparathyroidism (HPT)

THERAPEUTIC INDICATIONS

Treatment of secondary hyperparathyroidism (HPT) in adult patients with end-stage renal disease (ESRD) on maintenance dialysis therapy.

Cinecalcet Heaton 30 mg or Cinacalcet heaton 60 mg may be used as part of a therapeutic regimen including phosphate binders and/or Vitamin D sterols.

 

 Reduction of hypercalcaemia in adult patients with:

• parathyroid carcinoma

• primary HPT for whom parathyroidectomy would be indicated on the basis of serum calcium levels (as defined by relevant treatment guidelines), but in whom parathyroidectomy is not clinically appropriate or is contraindicated

DISPENSING AND REIMBURSEMENT

Medicinal product is subjected to medical prescription. The medicinal product is covered by public health insurance.


Cinacalcet 30 mg

 

Cinacalcet 60 mg